Form 10-Q · Quarterly report
Illinois Tool Works 10-Q, filed Oct 28, 2026
- Filed
- CIK
- 0000049826
- Accession no.
- 0000049826-26-000060
Summary
Illinois Tool Works described its seven reporting segments, its ITW Business Model, and its Next Phase 2024–2030 strategy, setting high-quality organic growth of 4% or more through the cycle as its highest priority. It also said its four Russian subsidiaries were not material to its results or financial position and that the U.S. Supreme Court invalidated many IEEPA tariffs in February 2026.
Key points
- ITW had 88 divisions and approximately 43,000 people in 49 countries as of December 31, 2025.
- ITW's seven segments are Automotive OEM; Food Equipment; Test & Measurement and Electronics; Welding; Polymers & Fluids; Construction Products; and Specialty Products.
- ITW's Next Phase (2024–2030) targets high-quality organic growth of 4% or more through the cycle.
- ITW's four Russian subsidiaries had net assets of approximately $41 million as of September 30, 2026, and were not material to its results of operations or financial position.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations INTRODUCTION Illinois Tool Works Inc. (the "Company" or "ITW") is a global manufacturer of a diversified range of industrial products and equipment. As of December 31, 2025, the Company had 88 divisions with approximately 43,000 people in 49 countries. The Company's operations are organized and managed based on similar product offerings and end markets, and are reported to senior management as the following seven segments: Automotive OEM; Food Equipment; Test & Measurement and Electronics; Welding; Polymers & Fluids; Construction Products; and Specialty Products. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.